Clinical Trial Update: Clinical Trial of the Optimal Endpoint of Early Sepsis Resuscitation [NA]

View source ↗

Summary

This entry notes that the National Institute of General Medical Sciences–sponsored trial on the optimal endpoint for early sepsis resuscitation has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis
• Septic Shock

Snippet

Sponsor: National Institute of General Medical Sciences (NIGMS) | Conditions: Severe Sepsis, Septic Shock | NA | Status: COMPLETED